Clinical trial
Quality of Life and Cognitive Functioning as Prognostic Factor in Glial Tumours
NCT07416838 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality of Life and Cognitive Functioning as Prognostic Factor in Glial Tumours
- Lead sponsor
- Institute of Oncology Ljubljana
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 21, 2018
- Completion date
- December 31, 2024
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glial tumors